• Currently Enrolling Studies
• What is a Clinical Trial?
• Phases of Research
• How to Get Involved
• Privacy Statement
• FAQ's
• Research Participation Survey

Diabetes Type II Delivers medication with low maintenance

	Study Medication:		Device
	Inclusion Criteria:		Currently Taking Oral Anti-diabetic Medication;  Oral Meds and Diet Control only
	Study Length:		Overnight stays
	Location:		Phase I: CPU
	Compensation:		up to $1850.00

Diabetes Type II Investigative study on controlling blood sugars

	Study Medication:		Oral Pill;  Metformin
	Inclusion Criteria:		Currently Taking Oral Anti-diabetic Medication
	Study Length:		33 weeks
	Location:		Phase II-IV: Main Research
	Compensation:		up to $800.00

Neuropathy Oral medication

	Study Medication:		Oral Pill
	Inclusion Criteria:		Numbness/Pain/Tingling Feet
	Study Length:		17 weeks
	Location:		Phase II-IV: Main Research
	Compensation:		up to $1065.00

Neuropathy Topical solution therapy for Neuropathy

	Study Medication:		Analgesic Therapy--ointment
	Inclusion Criteria:		Type II Diabetes
	Study Length:		5 months
	Location:		Phase II-IV: Main Research
	Compensation:		up to $1000.00

Weight Loss Study effects of long acting diabetic medications

	Study Medication:		Injectible and Oral
	Inclusion Criteria:		Type II Diabetes;  Must be taking metformin alone or in combination with other oral meds
	Study Length:		2 1/2 years
	Location:		Phase II-IV: Main Research
	Compensation:		up to $800.00